UK Biotech Financing Holds Up Despite Woodford and Brexit
Neil Woodford’s Fall From Grace And Brexit Dragged On An Otherwise Buoyant Sector
Neil Woodford’s fall from grace and Brexit dragged on an otherwise buoyant sector.
You may also be interested in...
With a long turnaround process now complete, AstraZeneca could hit double digit growth in 2020, thanks to existing products and new approvals such as roxadustat.
Partnership includes provision for fast-tracked uptake of inclisiran in England, if NICE finds it cost effective.